YAP is involved in CF activation, as evidenced in vivo by increased expressions of YAP and its target genes connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61) during the development of cardiac fibrosis in our rat MI model (Supplementary Fig. S16a, b). This evidence concerns the gene CCN2 and cystic fibrosis.